Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 6,357,928 8.480% |
946,638 (+17.49%) |
Filing History |
| 2025-02-14 4:33 pm Sale |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 4,683,711 6.250% |
-2,251,271 (-32.46%) |
Filing History |
| 2025-02-14 10:02 am Unchanged |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing History |
| 2025-02-14 06:27 am Sale |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Opaleye Management Inc. | 0 0.000% |
-820,000 (Position Closed) |
Filing History |
| 2025-02-12 5:20 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Lehr Martin A. | 1,595,742 2.100% |
143,276 (+9.86%) |
Filing History |
| 2025-01-27 12:55 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
FRANKLIN RESOURCES INC BEN |
4,003,380 5.300% |
4,003,380 (New Position) |
Filing History |
| 2025-01-08 4:07 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
MPM BioImpact LLC | 14,705,882 16.400% |
14,705,882 (New Position) |
Filing History |
| 2024-11-14 5:31 pm Unchanged |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 5,411,290 7.220% |
5,411,290 (New Position) |
Filing History |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 6,934,982 9.250% |
-484,373 (-6.53%) |
Filing History |
| 2024-11-06 5:08 pm Unchanged |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Hudson Bay Capital Management LP | 1,000,000 1.320% |
0 (Unchanged) |
Filing History |
| 2024-06-05 10:45 am Purchase |
2024-05-31 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 7,419,355 9.890% |
7,419,355 (New Position) |
Filing History |
| 2024-05-24 4:15 pm Purchase |
2024-05-06 | 13G | Context Therapeutics Inc. CNTX |
Nextech Crossover I GP S.a r.l. | 7,419,355 9.900% |
7,419,355 (New Position) |
Filing History |
| 2024-05-13 10:37 am Purchase |
2024-05-02 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
7,776,296 (New Position) |
Filing History |
| 2024-05-10 4:00 pm Purchase |
2024-05-02 | 13G | Context Therapeutics Inc. CNTX |
Deep Track Capital, LP | 7,419,355 9.890% |
7,419,355 (New Position) |
Filing History |
| 2024-02-13 4:45 pm Sale |
2023-12-31 | 13G | Context Therapeutics Inc. CNTX |
Affinity Healthcare Fund, LP | 328,817 2.060% |
-554,837 (-62.79%) |
Filing History |
| 2024-02-07 4:24 pm Purchase |
2023-12-31 | 13G | Context Therapeutics Inc. CNTX |
Lehr Martin A. | 1,452,466 8.800% |
1,452,466 (New Position) |
Filing History |
| 2024-01-05 4:05 pm Purchase |
2023-12-27 | 13G | Context Therapeutics Inc. CNTX |
Opaleye Management Inc. | 820,000 5.140% |
820,000 (New Position) |
Filing History |
| 2023-02-14 4:03 pm Purchase |
2022-12-31 | 13G | Context Therapeutics Inc. CNTX |
Context Therapeutics Inc. CNTX |
1,186,102 7.300% |
1,186,102 (New Position) |
Filing History |
| 2023-01-10 2:47 pm Sale |
2022-12-31 | 13G | Context Therapeutics Inc. CNTX |
SABBY MANAGEMENT LLC | 796,706 11.000% |
-434,124 (-35.27%) |
Filing History |